EUVIMED · CrossrefJournal
Prostate Cancer and Prostatic Diseases
ISSN 1365-7852 · Springer Science and Business Media LLC
Latest articles
Anatomy of periprostatic nerves and nerve-sparing strategy for radical prostatectomy
Phase I trial of using a prostatic urethral lift implant with stereotactic ablative body radiotherapy for men with prostate cancer and benign prostatic hyperplasia (NCT05311527)
Baseline and early changes in neutrophil-lymphocyte ratio as a prognostic biomarker with 177Lu-PSMA-617 therapy in advanced prostate cancer
PRAISE-U: from pilot to program—what clinicians need to know from population-based screening for prostate cancer
Bone fractures and prior abiraterone use in men treated with radium-223 plus enzalutamide for castration-resistant prostate cancer with bone metastases: a real-world study
Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial
Robot-assisted MRI/US transperineal target prostate biopsy with Biobot Mona Lisa 2.0: first experience in Europe
Predictors of durability of the prostatic urethral lift (PUL) for benign prostatic hyperplasia
Risk factors for incidental prostate cancer following surgery for benign prostatic enlargement: A systematic review and meta-analysis
A randomized controlled trial comparing en-bloc vs lobe-by-lobe HoLEP: surgical efficiency and early continence outcomes
Neuroscience in prostate cancer
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study
Radical prostatectomy without prior biopsy: an initial decision-making algorithm based on PSMA PET/mpMRI
Correction: Navigating drug–drug interactions with apalutamide
En-bloc vs lobe-by-lobe laser prostatectomy: where do we stand?
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial
Focal therapy for localized prostate cancer: not all that glitters is gold
Successful cabazitaxel desensitization after severe taxane hypersensitivity reactions: a brief report
Counseling is counseling is counseling is counseling - The evolution of LUTS/BPO care
Zenflow spring system for benign prostatic hyperplasia - 24 month outcomes of the ZEST pilot studies
Biochemical recurrence after radical prostatectomy: Where do we stand to?
Transperineal laser ablation in the management of benign prostatic hyperplasia: an updated systematic review and pooled analysis
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients
Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model
Perioperative outcomes comparing the DaVinci 5 with DaVinci Xi in patients undergoing robotic-assisted radical prostatectomy
Lymph node dissection based on 18F-PSMA PET/CT during radical prostatectomy for intermediate and high risk prostate cancer: interim results of a prospective, randomized study
Prognostic factors of PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
Beyond PSMA: theranostic cell surface targets in metastatic prostate cancer
AI-aided diagnostic performance for prostate MRI: systematic review and meta-analysis
EUVIMED